Key result
Pathogenic mitochondrial DNA point mutations and major deletions were not detected in any of the 62 patients with idiopathic cardiomyopathy or 75 controls.
Why the study?
Are pathogenic mitochondrial DNA mutations a common feature of idiopathic cardiomyopathy?
Case-Control (n=137)
Are pathogenic mitochondrial DNA mutations a common feature of idiopathic cardiomyopathy?
Pathogenic mitochondrial DNA mutations are not a common feature of idiopathic dilated or hypertrophic cardiomyopathy.
Suggests pathogenic mtDNA mutations are uncommon in idiopathic cardiomyopathy; leaves open roles in rare subsets pending larger studies.
AIMS: To investigate the frequency of pathogenic mitochondrial DNA mutations in idiopathic cardiomyopathy. METHODS AND RESULTS: We investigated the occurrence of seven previously reported pathogenic mitochondrial DNA point mutations in 52 patients with idiopathic dilated cardiomyopathy (blood n=33, myocardium n=19), 10 patients with hypertrophic cardiomyopathy (blood n=7, myocardium n=3), 67 controls with ischaemic heart disease (blood n=53, myocardium n=14) and eight controls with no overt cardiac disease (blood n=4, myocardium n=4). Total DNA or cell lysates were studied by polymerase chain reaction amplification and restriction fragment length polymorphism analysis for the identification of the following mitochondrial DNA point mutations: A3243G, A3252G, A3260G, A4269G, A8344G, T8993G/C and T9997C. None of these point mutations were detected in the blood or myocardium of any of the individuals with dilated or hypertrophic cardiomyopathy or in the controls. In addition we investigated the occurrence of major deletions of mitochondrial DNA in eight patients with dilated cardiomyopathy (myocardium n=7, skeletal muscle n=1), three patients with ischaemic heart disease (myocardium n=3) and one control myocardium by Southern blot analysis. Deletions were not detected in any of the patients. CONCLUSION: The results suggest that although these mutations are known to be associated with specific cardiomyopathies, they are not a common feature of idiopathic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Louise A. Turner (1998) conducted a case-control in Idiopathic cardiomyopathy (n=137). Pathogenic mitochondrial DNA mutations vs. Controls with ischaemic heart disease or no overt cardiac disease was evaluated on Occurrence of seven pathogenic mitochondrial DNA point mutations and major deletions. Pathogenic mitochondrial DNA point mutations and major deletions were not detected in any of the 62 patients with idiopathic cardiomyopathy or 75 controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: